BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 10454327)

  • 1. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics.
    Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC
    Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous transforming growth factor beta(2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats.
    Wang X; Smith P; Pu LL; Kim YJ; Ko F; Robson MC
    J Surg Res; 1999 Dec; 87(2):194-200. PubMed ID: 10600349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta2 activates proliferative scar fibroblasts.
    Smith P; Mosiello G; Deluca L; Ko F; Maggi S; Robson MC
    J Surg Res; 1999 Apr; 82(2):319-23. PubMed ID: 10090846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vivo model of human proliferative scar.
    Polo M; Kim YJ; Kucukcelebi A; Hayward PG; Ko F; Robson MC
    J Surg Res; 1998 Feb; 74(2):187-95. PubMed ID: 9587359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
    Sato M
    Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids.
    Lee TY; Chin GS; Kim WJ; Chau D; Gittes GK; Longaker MT
    Ann Plast Surg; 1999 Aug; 43(2):179-84. PubMed ID: 10454326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.
    Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y
    Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.
    Zhang Z; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
    Burns; 2007 Aug; 33(5):634-41. PubMed ID: 17374457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tamoxifen therapy in hypertrophic scars or keloids in burns.
    Gragnani A; Warde M; Furtado F; Ferreira LM
    Arch Dermatol Res; 2010 Jan; 302(1):1-4. PubMed ID: 19636578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keloids and hypertrophic scars: are they two different sides of the same coin?
    Köse O; Waseem A
    Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars.
    Niessen FB; Andriessen MP; Schalkwijk J; Visser L; Timens W
    J Pathol; 2001 Jun; 194(2):207-16. PubMed ID: 11400150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Replication of pathological scar in nude mice].
    Jin PS; Cen Y; Liu XX; Chen JJ; Xu XW; Liu Y; Li JJ; Wang Y
    Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):126-9. PubMed ID: 17649888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin stimulates production of bFGF and TGF-beta 1 by human normal, keloid, and fetal dermal fibroblasts.
    Carroll LA; Koch RJ
    Med Sci Monit; 2003 Mar; 9(3):BR97-108. PubMed ID: 12640331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring.
    Wang J; Jiao H; Stewart TL; Shankowsky HA; Scott PG; Tredget EE
    Wound Repair Regen; 2007; 15(4):530-9. PubMed ID: 17650097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
    Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of alpha-smooth muscle actin in scar fibroblasts in vitro].
    Huang H; Tang SJ; Bao WH
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Nov; 15(6):347-50. PubMed ID: 11762220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal expression of the transforming growth factor-Beta pathway in the rabbit ear model of wound healing and scarring.
    Kryger ZB; Sisco M; Roy NK; Lu L; Rosenberg D; Mustoe TA
    J Am Coll Surg; 2007 Jul; 205(1):78-88. PubMed ID: 17617336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.
    Colwell AS; Phan TT; Kong W; Longaker MT; Lorenz PH
    Plast Reconstr Surg; 2005 Oct; 116(5):1387-90; discussion 1391-2. PubMed ID: 16217483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.